Age, Biography and Wiki

Alejandro Zaffaroni was born on 27 February, 1923 in Montevideo, Uruguay, is an American businessman and biotechnology entrepreneur. Discover Alejandro Zaffaroni's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is he in this year and how he spends money? Also learn how he earned most of networth at the age of 91 years old?

Popular As N/A
Occupation N/A
Age 91 years old
Zodiac Sign Pisces
Born 27 February 1923
Birthday 27 February
Birthplace Montevideo, Uruguay
Date of death 2014
Died Place Atherton, California, US
Nationality Uruguay

We recommend you to check the complete list of Famous People born on 27 February. He is a member of famous businessman with the age 91 years old group.

Alejandro Zaffaroni Height, Weight & Measurements

At 91 years old, Alejandro Zaffaroni height not available right now. We will update Alejandro Zaffaroni's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.

Physical Status
Height Not Available
Weight Not Available
Body Measurements Not Available
Eye Color Not Available
Hair Color Not Available

Who Is Alejandro Zaffaroni's Wife?

His wife is Lida Zaffaroni

Family
Parents Not Available
Wife Lida Zaffaroni
Sibling Not Available
Children Not Available

Alejandro Zaffaroni Net Worth

His net worth has been growing significantly in 2023-2024. So, how much is Alejandro Zaffaroni worth at the age of 91 years old? Alejandro Zaffaroni’s income source is mostly from being a successful businessman. He is from Uruguay. We have estimated Alejandro Zaffaroni's net worth, money, salary, income, and assets.

Net Worth in 2024 $1 Million - $5 Million
Salary in 2024 Under Review
Net Worth in 2023 Pending
Salary in 2023 Under Review
House Not Available
Cars Not Available
Source of Income businessman

Alejandro Zaffaroni Social Network

Instagram
Linkedin
Twitter
Facebook
Wikipedia
Imdb

Timeline

1923

Alejandro Zaffaroni (February 27, 1923 – March 1, 2014) was a Uruguayan serial entrepreneur who was responsible for founding several biotechnology companies in Silicon Valley.

Products that he was involved in developing include the birth control pill, the nicotine patch, corticosteroids, and the DNA microarray.

Zaffaroni was born on February 27, 1923, in Montevideo.

Zaffaroni was of Italian descent, as his grandfather migrated from Italy to Uruguay at the age of 16.

Both of Zaffaroni's parents passed away early in his life; his mother when he was 12 and his father when he was 18.

His father was in the banking business.

1945

Zaffaroni received his Bachelor of Science degree from the University of the Republic in 1945, and his Ph.D. in biochemistry from the University of Rochester in 1949.

1951

Zaffaroni joined Syntex, then a small chemical company in Mexico, as a biochemist in 1951.

He participated in turning Syntex into a major multinational pharmaceutical company, moving it to Palo Alto, California.

1962

He was appointed president of the U.S. subsidiary in 1962.

1968

In 1968, he founded ALZA, a syllabic abbreviation of his name, to develop medical treatments through controlled drug delivery.

He modeled new delivery systems after the processes discovered in endocrinology – where glands deliver very small amounts of hormones but have a tremendous effect –.

ALZA's first controlled drug delivery product was used to treat glaucoma.

Other products that incorporated Zaffaroni's drug delivery technologies include Glucotrol, for non insulin-dependent diabetes; Duragesic, for management of severe chronic pain; NicoDerm CQ, for smoking cessation; and Transderm-Scop, to prevent nausea and vomiting associated with motion sickness.

1979

In 1979 Zaffaroni was awarded the Chemical Pioneer Award by the American Institute of Chemists In 1995, he received the National Medal of Technology from President Bill Clinton for his contributions to the pharmaceutical and biotechnology industries.

1980

In 1980, Zaffaroni established DNAX, a developer of macromolecular products that combines the technologies of genetic engineering and immunobiology.

1988

In 1988 he co-founded Affymax, specializing in combinatorial chemistry to reduce the cost and time of identifying new medicines.

1991

In 1991 he co-founded Affymetrix, specializing in using genetics for developing new medicine.

He was also involved in the creation of Perlegen Sciences, an Affymetrix spin-off which works on finding genetic causes of disease.

1994

In 1994, he founded Symyx Technologies, a company dedicated to utilizing combinatorial chemistry technologies.

1997

Other companies he founded include Maxygen (1997), a developer of technologies that improve the development of proteins and genetic elements, and SurroMed, focusing on the development of technologies for surrogate disease markers.

2000

In 2000, he founded Alexza Pharmaceuticals, a company working on rapid onset of action drug delivery technologies.

2004

In 2004, he was one of the recipients of the Winthrop-Sears Medal from the Chemical Heritage Foundation and The Chemists’ Club, with George Rosenkranz.

2005

In 2005 he received the Bower Award for Business Leadership from the Franklin Institute for his creation of new biochemical processes and drug delivery technologies.

In 2005 he was awarded the Gregory Pincus Award from the Worcester Foundation.

2006

In 2006, he received the Biotechnology Heritage Award, from the Biotechnology Industry Organization (BIO) and the Chemical Heritage Foundation.

2014

He died at his home at Atherton, California, on March 1, 2014.

He was 91.